Aspen Aerogels (ASPN) Misses Q3 EPS by 11c, Beats on Revenue; Offers FY24 Revenue Guidance

Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.17), $0.11 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $117.3 million versus the consensus estimate of $107.85 million.

GUIDANCE:

Aspen Aerogels sees FY2024 revenue of $450 million, versus the consensus of $415.2 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS